Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability and pharmacokinetics of GSK2269557 in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK2269557

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2019-01-14